跳至主要内容
临床试验/CTRI/2025/01/079515
CTRI/2025/01/079515尚未招募3 期

A randomised double arm parallel clinical study to compare the effectiveness of Urtica Urens mother tincture versus Individualised homoeopathic medicine in the management of Gout

Dr Nandini Maurya1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年2月3日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Gout Impact Scale

研究概览

简要总结

The study will be a Prospective, Double Arm Parallel group, open label,

Randomized clinical study. Patients will be randomly allocated in 1:1 ratio by using

computerised Block Randomization into 2 groups: URTICA URENS MOTHER TINCTURE

treatment group and INDIVIDUALISED HOMOEOPATHIC MEDICINE treatment group.

Primary objective is to evaluate which is more effective i.e., URTICA URENS MOTHER TINCTURE or

INDIVIDUALISED HOMOEOPATHIC MEDICINE in management of Gout and; to assess the improvement of patient in terms of frequency of attack and severity of symptoms of Gout.

Duration of study is 1 year. Sample size is 60; 30 in each group.

Research Analysis

Assessment of clinical response/ outcome.

Relief from symptoms and suffering.

Assessment of improvement by using Gout Impact Scale and Pain Visual Analogue

Scale.

Laboratory investigations: Serum Uric Acid

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients having sign and symptoms of Gout.
  • Pre diagnosed cases of Gout.
  • Patients who have not taken any treatment for gout in the last 2 weeks.
  • Patients with serum uric acid level over 7.0 mg/dl
  • Patients giving informed consent.
  • Patients willing to come for regular followups.

排除标准

  • Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled systemic illness or life- threatening infections affecting quality of life or any vital organ failure.
  • Pregnancy, puerperium and lactation.
  • Substance abuse and/or dependence.
  • Self-reported immune-compromised state.
  • Patients who are already enrolled in some other study.
  • Patients who are not willing to give the consent.

结局指标

主要结局

Gout Impact Scale

时间窗: 1 month

次要结局

  • Pain Visual Analogue Scale(1 month)
  • Serum Uric Acid Level(4 weeks)

研究者

发起方
Dr Nandini Maurya
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Nandini Maurya

Nehru Homoeopathic Medical College and Hospital

研究点 (1)

Loading locations...

相似试验

A study to compare the effectiveness of Urtica Urens... | 临床试验